Fan’s X-ray crystallography work at SLAC’s synchrotron moves us closer to a more protective coronavirus vaccine and a better understanding of how vital materials flow in and out of cells.

Powerful X-rays from SLAC’s synchrotron reveal that our immune system’s primary wiring seems to be no match for a brutal SARS-CoV-2 protein.

SLAC and Stanford scientists used it to zoom in on an iconic RNA catalyst and a piece of viral RNA that’s a potential target for COVID-19 treatments.

Two groups of researchers drew on SLAC tools to better understand how to target a key part of the virus that causes COVID-19.

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

Images reveal how some antibodies may block SARS-CoV-2 infection.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.